Doyle Mittie (CIK 1918845) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy AVTX (2,875 shares), Buy AVTX (1,779 shares), Sell AVTX (4,654 shares), Buy AVTX (1,450 shares), Sell AVTX (1,450 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 2,875 | $36,369 |
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 1,779 | $14,303 |
| 2026-07-02 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 4,654 | $93,080 |
| 2026-06-25 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 1,450 | $11,658 |
| 2026-06-25 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 1,450 | $26,100 |
| 2026-06-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 1,084 | $14,200 |
| 2026-06-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-06-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 679 | $10,864 |
| 2026-05-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 3,000 | $37,950 |
| 2026-05-19 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 3,000 | $56,280 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 1,679 | $26,864 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 1,000 | $12,650 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 77,905 | $985,498 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 28,650 | $230,346 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 27,538 | $496,405 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 5,000 | $98,251 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 44,944 | $952,669 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 19,015 | $426,050 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 10,058 | $230,127 |
| 2026-04-08 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 3,970 | $50,220 |
| 2026-04-08 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 3,970 | $71,508 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 679 | $5,459 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Sell | 679 | $10,864 |
| 2026-03-18 | Avalo Therapeutics, Inc. (AVTX) | Chief Medical Officer | Buy | 19,500 | $246,675 |
Source: SEC Form 4 filings · as of 2026-07-02